| Title: |
Travel history among persons infected with SARS-CoV-2 variants of concern in the United States, December 2020—February 2021 |
| Authors: |
Dunajcik, Alicia; Haire, Kambria; Thomas, Jennifer D.; Moriarty, Leah F.; Springer, Yuri; Villanueva, Julie M.; MacNeil, Adam; Silk, Benjamin; Nemhauser, Jeffrey B.; Byrkit, Ramona; Taylor, Melanie; Queen, Krista; Tong, Suxiang; Lee, Justin; Batra, Dhwani; Paden, Clinton; Henderson, Tiffany; Kunkes, Audrey; Ojo, Mojisola; Firestone, Melanie; Martin Webb, Lindsey; Freeland, Melissa; Brown, Catherine M.; Williams, Thelonious; Allen, Krisandra; Kauerauf, Judy; Wilson, Erica; Jain, Seema; McDonald, Eric; Silver, Elana; Stous, Sarah; Wadford, Debra; Radcliffe, Rachel; Marriott, Chandra; Owes, Jennifer P.; Bart, Stephen M.; Sosa, Lynn E.; Oakeson, Kelly; Wodniak, Natalie; Shaffner, Julia; Brown, Quanta; Westergaard, Ryan; Salinas, Andrea; Hallyburton, Sara; Ogale, Yasmin; Offutt-Powell, Tabatha; Bonner, Kimberly; Tubach, Sheri; Van Houten, Clay; Hughes, Victoria |
| Contributors: |
Escandón, Kevin |
| Source: |
PLOS Global Public Health ; volume 3, issue 3, page e0001252 ; ISSN 2767-3375 |
| Publisher Information: |
Public Library of Science (PLoS) |
| Publication Year: |
2023 |
| Collection: |
PLOS Publications (via CrossRef) |
| Description: |
The first three SARS-CoV-2 phylogenetic lineages classified as variants of concern (VOCs) in the United States (U.S.) from December 15, 2020 to February 28, 2021, Alpha (B.1.1.7), Beta (B.1.351), and Gamma (P.1) lineages, were initially detected internationally. This investigation examined available travel history of coronavirus disease 2019 (COVID-19) cases reported in the U.S. in whom laboratory testing showed one of these initial VOCs. Travel history, demographics, and health outcomes for a convenience sample of persons infected with a SARS-CoV-2 VOC from December 15, 2020 through February 28, 2021 were provided by 35 state and city health departments, and proportion reporting travel was calculated. Of 1,761 confirmed VOC cases analyzed, 1,368 had available data on travel history. Of those with data on travel history, 1,168 (85%) reported no travel preceding laboratory confirmation of SARS-CoV-2 and only 105 (8%) reported international travel during the 30 days preceding a positive SARS-CoV-2 test or symptom onset. International travel was reported by 92/1,304 (7%) of persons infected with the Alpha variant, 7/55 (22%) with Beta, and 5/9 (56%) with Gamma. Of the first three SARS-CoV-2 lineages designated as VOCs in the U.S., international travel was common only among the few Gamma cases. Most persons infected with Alpha and Beta variant reported no travel history, therefore, community transmission of these VOCs was likely common in the U.S. by March 2021. These findings underscore the importance of global surveillance using whole genome sequencing to detect and inform mitigation strategies for emerging SARS-CoV-2 VOCs. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1371/journal.pgph.0001252 |
| Availability: |
https://doi.org/10.1371/journal.pgph.0001252; https://dx.plos.org/10.1371/journal.pgph.0001252 |
| Rights: |
https://creativecommons.org/publicdomain/zero/1.0/ |
| Accession Number: |
edsbas.18B2860F |
| Database: |
BASE |